New combo therapy targets Hard-to-Treat prostate cancer
NCT ID NCT05367440
First seen Sep 30, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tests a new drug (AZD5305) combined with standard hormone therapies in people with metastatic prostate cancer that has spread. The goal is to check safety, how the drug moves through the body, and early signs of effectiveness. About 174 adults whose cancer has spread and who are candidates for hormone therapy will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Detroit, Michigan, 48201, United States
-
Research Site
Detroit, Michigan, 48202, United States
-
Research Site
Syracuse, New York, 13210, United States
-
Research Site
Myrtle Beach, South Carolina, 29572, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
Houston, Texas, 77094, United States
-
Research Site
Camperdown, 2050, Australia
-
Research Site
Darlinghurst, 2010, Australia
-
Research Site
East Melbourne, 3002, Australia
-
Research Site
Heidelberg, 3084, Australia
-
Research Site
Melbourne, 3004, Australia
-
Research Site
St Leonards, 2065, Australia
-
Research Site
Candiolo, 10060, Italy
-
Research Site
Milan, 20133, Italy
-
Research Site
Orbassano, 10043, Italy
-
Research Site
Padova, 35128, Italy
-
Research Site
Cambridge, CB2 0QQ, United Kingdom
-
Research Site
Glasgow, G12 0YN, United Kingdom
-
Research Site
Manchester, M20 4BX, United Kingdom
-
Research Site
Plymouth, PL6 8DH, United Kingdom
Conditions
Explore the condition pages connected to this study.